导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -23.82% | 7/7 |
| 近一周 | -2.44% | 3/9 |
| 近一月 | -2.78% | 3/9 |
| 近一季 | -5.98% | 7/9 |
| 近半年 | -21.30% | 7/7 |
| 近一年 | -29.80% | 1/1 |
| 近两年 | -3.08% | 1/1 |
| 近三年 | -27.91% | 1/1 |
| 成立以来 | 624.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.51% 90/109 |
-19.03% 109/119 |
- - |
- - |
| 2025 | 8.46% 92/108 |
8.40% 53/97 |
-7.07% 97/99 |
17.58% 52/104 |
-8.42% 58/108 |
| 2024 | 1.80% 76/97 |
-0.42% 55/89 |
-3.82% 72/94 |
17.90% 17/97 |
-9.84% 91/97 |
| 2023 | -21.53% 67/93 |
0.76% 37/73 |
-11.59% 63/77 |
-0.94% 15/82 |
-11.07% 82/93 |
| 2022 | -14.42% 15/71 |
-17.06% 34/58 |
13.47% 5/62 |
-14.39% 37/68 |
6.23% 32/71 |
| 2021 | -13.39% 25/58 |
-4.62% 948/1745 |
2.51% 1553/2232 |
-10.30% 1755/2560 |
-1.25% 11/58 |
| 2020 | 84.35% 4/38 |
-4.70% 707/1036 |
28.19% 336/1256 |
18.24% 161/1472 |
27.62% 66/1690 |
| 2019 | 65.76% 1/30 |
35.16% 177/3054 |
11.40% 21/3201 |
5.26% 479/939 |
4.59% 832/1014 |
| 2018 | -14.30% 12/28 |
- - |
- - |
- - |
-15.23% 2717/2977 |
| 2017 | 46.82% 2/20 |
- - |
- - |
- - |
- - |
| 2016 | 8.30% 2/17 |
- - |
- - |
- - |
- - |
| 2015 | 25.79% 1/16 |
- - |
- - |
- - |
- - |
| 2014 | 31.43% 127/432 |
- - |
- - |
- - |
- - |
| 2013 | 9.61% 258/398 |
- - |
- - |
- - |
- - |
| 2012 | 5.25% 199/459 |
- - |
- - |
- - |
- - |
| 2011 | -27.27% 294/392 |
- - |
- - |
- - |
- - |
| 2010 | 14.57% 50/335 |
- - |
- - |
- - |
- - |
| 2009 | 74.69% 73/270 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 摩根中国生物医药混合(QDII)A | 1.4779 | 18.54% |
| 南方港股医药行业混合发起(QDII)A | 1.3423 | 18.34% |
| 摩根中国生物医药混合(QDII)C | 1.4554 | 17.49% |
| 南方港股医药行业混合发起(QDII)C | 1.2936 | 15.12% |
| 东方红医疗创新混合(QDII)A | 0.8769 | 15.09% |
| 东方红医疗创新混合(QDII)C | 0.8725 | 14.94% |
| 富国医药精选混合(QDII)A | 0.9730 | 9.63% |
| 长城港股医疗保健精选混合发起(QDII)C | 0.7545 | 8.73% |
| 长城港股医疗保健精选混合发起(QDII)A | 0.7593 | 8.70% |
| 富国医药精选混合(QDII)C | 0.9680 | 8.18% |
| 易方达优质精选混合(QDII) VS. 建信新兴市场混合(QDII)A(539002) |